Omega Therapeutics, Inc. Quarterly Lessee, Operating Lease, Liability, to be Paid, Year Three in USD from Q2 2021 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Summary
Omega Therapeutics, Inc. quarterly Lessee, Operating Lease, Liability, to be Paid, Year Three history and growth rate from Q2 2021 to Q2 2024.
  • Omega Therapeutics, Inc. Lessee, Operating Lease, Liability, to be Paid, Year Three for the quarter ending June 30, 2024 was $12.7M.
Lessee, Operating Lease, Liability, to be Paid, Year Three, Quarterly (USD)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $12.7M Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $12.5M Mar 31, 2024 10-Q 2024-05-06
Q4 2023 $12.2M Dec 31, 2023 10-K 2024-03-28
Q4 2021 $11.8M Dec 31, 2021 10-K 2022-03-10
Q3 2021 $1.21M Sep 30, 2021 10-Q 2021-11-10
Q2 2021 $1.21M Jun 30, 2021 10-Q 2021-09-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.